[go: up one dir, main page]

NO20041607L - Doseringsregime og farmasoytisk preparat for nodprevensjon - Google Patents

Doseringsregime og farmasoytisk preparat for nodprevensjon

Info

Publication number
NO20041607L
NO20041607L NO20041607A NO20041607A NO20041607L NO 20041607 L NO20041607 L NO 20041607L NO 20041607 A NO20041607 A NO 20041607A NO 20041607 A NO20041607 A NO 20041607A NO 20041607 L NO20041607 L NO 20041607L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
dosage regimen
node
prevention
node prevention
Prior art date
Application number
NO20041607A
Other languages
English (en)
Other versions
NO333984B1 (no
Inventor
Paul F A Van Look
Illesne Bologh
Katalin Komandi
Laszlo Nemes
Zsolt Szabo
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO20041607L publication Critical patent/NO20041607L/no
Publication of NO333984B1 publication Critical patent/NO333984B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO20041607A 2001-11-27 2004-04-20 Farmasøytisk preparat for nødprevensjon og anvendelse derav. NO333984B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel
PCT/HU2002/000129 WO2003045397A1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception

Publications (2)

Publication Number Publication Date
NO20041607L true NO20041607L (no) 2004-04-20
NO333984B1 NO333984B1 (no) 2013-11-04

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041607A NO333984B1 (no) 2001-11-27 2004-04-20 Farmasøytisk preparat for nødprevensjon og anvendelse derav.

Country Status (33)

Country Link
US (1) US20050288264A2 (no)
EP (1) EP1448207B1 (no)
JP (1) JP2005516904A (no)
KR (1) KR100908161B1 (no)
CN (1) CN1551774A (no)
AP (1) AP1849A (no)
AT (1) ATE293978T1 (no)
AU (1) AU2002347401A1 (no)
BR (1) BR0210595A (no)
CA (1) CA2450359C (no)
DE (1) DE60203929T2 (no)
DK (1) DK1448207T3 (no)
EA (1) EA006545B1 (no)
EC (1) ECSP045171A (no)
ES (1) ES2239727T3 (no)
GE (1) GEP20063882B (no)
HR (1) HRP20040584B1 (no)
HU (1) HU227198B1 (no)
IL (1) IL159394A0 (no)
IS (1) IS2691B (no)
MA (1) MA27076A1 (no)
MX (1) MXPA04005104A (no)
NO (1) NO333984B1 (no)
NZ (1) NZ530056A (no)
OA (1) OA12730A (no)
PL (1) PL206010B1 (no)
PT (1) PT1448207E (no)
RS (1) RS50768B (no)
SI (1) SI1448207T1 (no)
TN (1) TNSN04048A1 (no)
UA (1) UA79942C2 (no)
WO (1) WO2003045397A1 (no)
ZA (1) ZA200404114B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
EA201070715A1 (ru) * 2007-12-20 2011-02-28 Тева Вимен'С Хелс, Инк. Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
US9180131B2 (en) 2008-12-12 2015-11-10 Laboratoire Hra Pharma Method for contraception
BRPI1014035A2 (pt) 2009-04-14 2016-04-12 Hra Pharma Lab método para contracepção.
EA023780B1 (ru) 2009-06-23 2016-07-29 Байер Интеллекчуал Проперти Гмбх Лекарственное средство для экстренной контрацепции
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
RS55293B1 (sr) 2011-06-01 2017-03-31 Estetra Sprl Postupak proizvodnje intermedijara estetrola
HRP20160692T2 (hr) 2011-06-01 2016-09-23 Estetra S.P.R.L. Postupak za proizvodnju intermedijera estetrola
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
LT2741824T (lt) * 2011-08-11 2017-06-26 Estetra S.P.R.L. Estetrolio panaudojimas kaip skubaus kontraceptiko
WO2014079840A1 (de) 2012-11-22 2014-05-30 Bayer Pharma Aktiengesellschaft Verwendung und anwendungsregime einer pharmazeutischen zusammensetzung enthaltend levonorgestrel und einen cox-inhibitor zur bedarfsweisen ("on-demand") kontrazeption
US9655887B2 (en) 2013-05-23 2017-05-23 Bayer Pharma Aktiengesellschaft Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
KR102664563B1 (ko) 2015-06-18 2024-05-09 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 에스테트롤 성분을 함유하는 구강분해성 투여 단위
HUE057741T2 (hu) 2015-06-18 2022-06-28 Estetra Srl Esztetrol komponenst tartalmazó, szájban diszpergálódó adagolási egység
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
US20230338355A1 (en) * 2020-07-30 2023-10-26 Acer Therapeutics Inc. Nk antagonists for contraception

Also Published As

Publication number Publication date
EP1448207A1 (en) 2004-08-25
DK1448207T3 (da) 2005-06-27
HUP0105173D0 (en) 2002-02-28
EA006545B1 (ru) 2006-02-24
EP1448207B1 (en) 2005-04-27
CA2450359C (en) 2011-05-10
AP2004003046A0 (en) 2004-06-30
WO2003045397A1 (en) 2003-06-05
HU227198B1 (en) 2010-10-28
AP1849A (en) 2008-05-23
HUP0105173A3 (en) 2004-03-29
KR20040066088A (ko) 2004-07-23
ZA200404114B (en) 2005-10-26
RS50768B (sr) 2010-08-31
BR0210595A (pt) 2004-06-08
JP2005516904A (ja) 2005-06-09
IS2691B (is) 2010-10-15
OA12730A (fr) 2006-06-28
KR100908161B1 (ko) 2009-07-16
AU2002347401A1 (en) 2003-06-10
SI1448207T1 (en) 2005-10-31
US20050288264A2 (en) 2005-12-29
TNSN04048A1 (en) 2006-06-01
HRP20040584A2 (en) 2005-02-28
HUP0105173A2 (hu) 2003-08-28
RS4204A (en) 2007-02-05
DE60203929T2 (de) 2006-01-19
US20050032755A1 (en) 2005-02-10
NZ530056A (en) 2005-02-25
PL369520A1 (en) 2005-04-18
PT1448207E (pt) 2005-08-31
IL159394A0 (en) 2004-06-01
ECSP045171A (es) 2004-08-27
GEP20063882B (en) 2006-07-25
ES2239727T3 (es) 2005-10-01
CN1551774A (zh) 2004-12-01
PL206010B1 (pl) 2010-06-30
NO333984B1 (no) 2013-11-04
DE60203929D1 (de) 2005-06-02
UA79942C2 (en) 2007-08-10
IS7065A (is) 2003-12-05
ATE293978T1 (de) 2005-05-15
HRP20040584B1 (en) 2012-11-30
EA200400731A1 (ru) 2004-12-30
MA27076A1 (fr) 2004-12-20
CA2450359A1 (en) 2003-06-05
MXPA04005104A (es) 2004-08-19

Similar Documents

Publication Publication Date Title
NO20041607L (no) Doseringsregime og farmasoytisk preparat for nodprevensjon
NO2023030I1 (no) Apixaban and pharmaceutical acceptable salts thereof
NO20033143D0 (no) Farmasoytisk preparat
NO20030418D0 (no) Nytt farmasöytisk preparat
PT1390063E (pt) Forma de dosagem farmaceutica de mesilato de nelfinavir amorfo
NO20033556L (no) Farmasöytiske formuleringer
ITTO20010008A0 (it) Formulazione farmaceutica
NO20030627L (no) Hydrogel-drevet medikament doseringsform
NO20033785L (no) Farmasöytisk formulering
NO20043904L (no) Oral doseringsform inneholdende en PDE4-hemmer som aktivt ingrediens og polyvinylpyrrolidon som eksipiens
NO20032517L (no) Farmasöytisk preparat inneholdende amlodipinmaleat
NO20035627D0 (no) Farmasöytisk formulering
NO20033042D0 (no) Cyklodekstrin-inneholdende farmasöytisk preparat
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
NO20025805D0 (no) Farmasöytisk preparat
IS7266A (is) Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DK200300348U4 (da) Fast farmaceutisk dosisform omfattende amlodipinmaleat
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DE10291905D2 (de) Pharmazeutische Zusammensetzung
NO20033162L (no) Farmasöytisk tablett omfattende paroksetinmesylat
NO20021036D0 (no) Farmasöytisk preparat
DE10107261B4 (de) Pharmazeutische Zusammensetzung
NO20041236L (no) Farmasoytisk formulering
UA5530S (uk) Таблетка фармацевтична

Legal Events

Date Code Title Description
MK1K Patent expired